Peers of Sagimet Biosciences Inc (SGMT)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-49.25x
As of Sep 27, 2024
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Sep 27, 2024 | -49.25x |
| Sep 26, 2024 | -49.25x |
| Sep 25, 2024 | -51.00x |
| Sep 24, 2024 | -48.61x |
| Sep 23, 2024 | -48.61x |
| Sep 20, 2024 | -44.14x |
| Sep 19, 2024 | -41.91x |
| Sep 18, 2024 | -40.31x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison